Authors
Loading...
Retrospective analysis showed 48.1% of patients experienced adverse drug reactions to antitubercular therapy, highlighting the need for clinical monitoring.
Neelam et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: